CD74 supports accumulation and function of regulatory T cells in tumors.

Saved in:
Bibliographic Details
Title: CD74 supports accumulation and function of regulatory T cells in tumors.
Authors: Bonnin E; INSERM U932 Immunity and Cancer, PSL University, Institut Curie Research Center, Paris, France.; Department of Translational Research, PSL Research University, Institut Curie Research Center, Paris, France., Rodrigo Riestra M; INSERM U932 Immunity and Cancer, PSL University, Institut Curie Research Center, Paris, France.; Department of Translational Research, PSL Research University, Institut Curie Research Center, Paris, France., Marziali F; INSERM U932 Immunity and Cancer, PSL University, Institut Curie Research Center, Paris, France.; Department of Translational Research, PSL Research University, Institut Curie Research Center, Paris, France., Mena Osuna R; INSERM U932 Immunity and Cancer, PSL University, Institut Curie Research Center, Paris, France.; Department of Translational Research, PSL Research University, Institut Curie Research Center, Paris, France., Denizeau J; INSERM U932 Immunity and Cancer, PSL University, Institut Curie Research Center, Paris, France.; Department of Translational Research, PSL Research University, Institut Curie Research Center, Paris, France., Maurin M; INSERM U932 Immunity and Cancer, PSL University, Institut Curie Research Center, Paris, France., Saez JJ; INSERM U932 Immunity and Cancer, PSL University, Institut Curie Research Center, Paris, France., Jouve M; INSERM U932 Immunity and Cancer, PSL University, Institut Curie Research Center, Paris, France., Bonté PE; INSERM U932 Immunity and Cancer, PSL University, Institut Curie Research Center, Paris, France., Richer W; INSERM U932 Immunity and Cancer, PSL University, Institut Curie Research Center, Paris, France.; Department of Translational Research, PSL Research University, Institut Curie Research Center, Paris, France., Nevo F; Egle Therapeutics, Paris, France., Lemoine S; Egle Therapeutics, Paris, France., Girard N; INSERM U932 Immunity and Cancer, PSL University, Institut Curie Research Center, Paris, France.; Paris Saclay University, UVSQ, Versailles, France.; Institut du Thorax Curie Montsouris, Institut Curie, Paris, France., Lefevre M; Pathology Department, Institut Mutualiste Montsouris, Paris, France., Borcoman E; Department of Drug Development and Innovation (D3i), Institut Curie, Paris, France., Vincent-Salomon A; Institut du Thorax Curie Montsouris, Institut Curie, Paris, France.; Diagnostic and Theranostic Medicine Division, Institut Curie, PSL Research University, Paris, France., Baulande S; Institut Curie Genomics of Excellence (ICGex) Platform, PSL Research University, Institut Curie Research Center, Paris, France., Moreau HD; INSERM U932 Immunity and Cancer, PSL University, Institut Curie Research Center, Paris, France., Sedlik C; INSERM U932 Immunity and Cancer, PSL University, Institut Curie Research Center, Paris, France.; Department of Translational Research, PSL Research University, Institut Curie Research Center, Paris, France., Hivroz C; INSERM U932 Immunity and Cancer, PSL University, Institut Curie Research Center, Paris, France., Lennon-Duménil AM; INSERM U932 Immunity and Cancer, PSL University, Institut Curie Research Center, Paris, France., Tosello Boari J; INSERM U932 Immunity and Cancer, PSL University, Institut Curie Research Center, Paris, France. jimena.tosello@curie.fr.; Department of Translational Research, PSL Research University, Institut Curie Research Center, Paris, France. jimena.tosello@curie.fr., Piaggio E; INSERM U932 Immunity and Cancer, PSL University, Institut Curie Research Center, Paris, France. eliane.piaggio@curie.fr.; Department of Translational Research, PSL Research University, Institut Curie Research Center, Paris, France. eliane.piaggio@curie.fr.; Egle Therapeutics, Paris, France. eliane.piaggio@curie.fr.
Source: Nature communications [Nat Commun] 2024 May 03; Vol. 15 (1), pp. 3749. Date of Electronic Publication: 2024 May 03.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE
Database: MEDLINE Ultimate
Be the first to leave a comment!
You must be logged in first